Package Leaflet: Information for the User
Levitra 20 mg film-coated tablets
vardenafil
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack and other information
Levitra contains vardenafil, which belongs to a group of medicines called phosphodiesterase 5 inhibitors. These medicines are used to treat erectile dysfunction in adult men, a condition which is also known as impotence. This is when a man cannot get, or keep a hard, erect penis suitable for sexual activity.
At least one in ten men has trouble getting or keeping an erection at some time. This can be due to physical or psychological factors, or a combination of both. Whatever the cause, the result is that there is not enough blood flow to the penis to achieve and maintain an erection.
Levitra will only work when you are sexually stimulated. It works by helping the blood vessels in your penis to relax, allowing the flow of blood into your penis. Levitra will not help you if you do not have erectile dysfunction. It is important to note that Levitra is not a hormone or an aphrodisiac.
Do not take Levitra
Warnings and precautions
Before taking Levitra, tell your doctor if you have:
Be cautious with Levitra
Children and adolescents
Levitra should not be used in children and adolescents under 18 years of age.
Other medicines and Levitra
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including those obtained without a prescription.
Some medicines may cause problems, especially:
Do not take Levitra film-coated tablets in combination with another medicine for erectile dysfunction, including Levitra orodispersible tablets.
Taking Levitra with food, drink and alcohol
You can take Levitra with or without food, but if you have a meal with a high fat content, it may take longer for Levitra to work.
Pregnancy and breast-feeding
Levitra is not for use by women.
Driving and using machines
Levitra may cause dizziness or affect your vision. Do not drive or operate machinery if you feel dizzy or have problems with your vision after taking Levitra.
Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.
The recommended dose is 10 mg.
Take a Levitra tablet about 25 to 60 minutes before sexual activity. With sexual stimulation, you may achieve an erection from 25 minutes up to 4-5 hours after taking Levitra.
Do not take Levitra film-coated tabletswith any other formulation of Levitra.
Do not take Levitramore than once a day.
If you think that the effect of Levitra is too strong or too weak, talk to your doctor. Your doctor may suggest that you take a different dose of Levitra.
If you take more Levitra than you should
Taking too much Levitra may cause more side effects and may make them more severe. If you take more Levitra than you should, tell your doctor.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them. Most of the side effects are mild or moderate.
Some patients have reported a sudden decrease or loss of vision in one or both eyes after taking Levitra. This can be a sign of an underlying condition called NAION (non-arteritic anterior ischemic optic neuropathy). If you experience any decrease or loss of vision while taking Levitra, stop taking the medicine and seek medical help immediately.
Some patients have reported a sudden decrease or loss of hearing after taking Levitra. If you experience any decrease or loss of hearing while taking Levitra, stop taking the medicine and seek medical help immediately.
There have been reports of heart attack, stroke, irregular heartbeat, and death in men taking vardenafil. Most of the men who experienced these side effects had pre-existing heart problems. It is not possible to determine whether these events were directly related to vardenafil.
The likelihood of experiencing a side effect is described in the following categories:
Very common side effects:
may affect more than 1 in 10 people
Common side effects:
may affect up to 1 in 10 people
Uncommon side effects:
may affect up to 1 in 100 people
Rare side effects:
may affect up to 1 in 1,000 people
Very rare or not known side effects:
may affect less than 1 in 10,000 people or the frequency cannot be estimated from the available data
Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton after EXP. The expiry date refers to the last day of that month.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
What Levitra contains
In the tablet core: crospovidone, magnesium stearate, microcrystalline cellulose, anhydrous colloidal silica.
In the film coating: macrogol 400, hypromellose, titanium dioxide (E171), yellow iron oxide (E172), red iron oxide (E172).
Appearance and packaging
Levitra 20 mg film-coated tablets are orange, round, and marked with the Bayer cross on one side and the strength (20) on the other. Each pack contains 2, 4, 8, 12 or 20 tablets. Not all pack sizes may be marketed.
Marketing authorisation holder and manufacturer
Marketing authorisation holder
Bayer AG
51368 Leverkusen
Germany
Manufacturer
Bayer AG
Kaiser-Wilhelm-Allee
51368 Leverkusen
Germany
For further information on this medicine, contact your local representative:
België/Belgique/Belgien | Lietuva |
Bayer SA-NV | UAB Bayer |
Tél/Tel: +32-(0)2-535 63 11 | Tel: +370 523 36 868 |
България | Luxembourg/Luxemburg |
Байер България ЕООД | Bayer SA-NV |
Тел.: +359-(0)2-424 72 80 | Tél/Tel: +32-(0)2-535 63 11 |
Česká republika | Magyarország |
Bayer s.r.o. | Bayer Hungária KFT |
Tel: +420 266 101 111 | Tel.: +36 14 87-4100 |
Danmark | Malta |
Bayer A/S | Alfred Gera and Sons Ltd. |
Tlf: +45 45 23 50 00 | Tel: +35 621 44 62 05 |
Deutschland | Nederland |
Jenapharm GmbH & Co. KG | Bayer B.V. |
Tel: +49 (0)3641-87 97 444 | Tel: +31-(0)297-28 06 66 |
Eesti | Norge |
Bayer OÜ | Bayer AS |
Tel: +372 655 85 65 | Tlf: +47-23 13 05 00 |
Ελλάδα | Österreich |
Bayer Ελλάς ΑΒΕΕ | Bayer Austria Ges. m. b. H. |
Τηλ: +30 210 61 87 500 | Tel: +43-(0)1-711 46-0 |
España | Polska |
Bayer Hispania S.L. | Bayer Sp. z o.o. |
Tel: +34-93-495 65 00 | Tel.: +48 22 572 35 00 |
France | Portugal |
Bayer HealthCare | Bayer Portugal, Lda. |
Tél (N° vert) : +33-(0)800 87 54 54 | Tel: +351 21 416 42 00 |
Hrvatska | România |
Bayer d.o.o. | SC Bayer SRL. |
Tel: + 385-(0)1-6599 900 | Tel: +40-21-529 59 00 |
Ireland | Slovenija |
Bayer Limited | Bayer d. o. o. |
Tel: +353 1 216 3300 | Tel: +386 (0)1 58 14 400 |
Ísland | Slovenská republika |
Icepharma hf. | Bayer, spol. s r.o. |
Sími: +354-540 8000 | Tel: +421 2-59 21 31 11 |
Italia | Suomi/Finland |
Bayer S.p.A. | Bayer Oy |
Tel: +39 02 397 81 | Puh/Tel: +358-20 785 21 |
Κύπρος | Sverige |
NOVAGEM Limited | Bayer AB |
Τηλ: +357 22 48 38 58 | Tel: +46 (0)8 580 223 00 |
Latvija | United Kingdom |
SIA Bayer | Bayer plc |
Tel: +371 67 845 563 | Tel: +44 (0) 118 206 3000 |
Date of last revision of this leaflet {month, year} Other sources of information
Detailed information on this medicine is available on the European Medicines Agency web site: http://www.ema.europa.eu